Insider Stock Trading History of Meyer Steven J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Meyer Steven J since year 2005. The trader's CIK number is 1124179. At the time of this reporting, Meyer Steven J is the Director of Insys Therapeutics, Inc. . (stock ticker symbol INSY). See this page for all insider trading activities at Insys Therapeutics, Inc. .

Note that in the past MEYER STEVEN J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Meyer Steven J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-18 INSY Insys Therapeutics, Inc. Buy 8,000 12.21 97,680
2016-11-04 INSY Insys Therapeutics, Inc. Buy 10,000 10.75 107,490
2016-09-01 INSY Insys Therapeutics, Inc. Option Ex 500 13.57 6,785
2016-08-04 INSY Insys Therapeutics, Inc. Option Ex 1,194 14.01 16,721
2016-07-06 INSY Insys Therapeutics, Inc. Option Ex 695 14.44 10,035
2016-06-07 INSY Insys Therapeutics, Inc. Option Ex 1,194 14.01 16,721
2016-06-02 AKRX Akorn Inc Option Ex 25,000 6.62 165,500
2016-05-18 INSY Insys Therapeutics, Inc. Option Ex 500 13.57 6,785
2016-04-14 INSY Insys Therapeutics, Inc. Option Ex 12,000 8.60 103,200
2016-02-05 INSY Insys Therapeutics, Inc. Option Ex 18,000 8.60 154,800
2015-06-05 INSY Insys Therapeutics, Inc. Sale 5,000 63.00 315,000
2015-05-11 INSY Insys Therapeutics, Inc. Option Ex 18,000 3.25 58,500
2015-05-11 INSY Insys Therapeutics, Inc. Sale 18,000 56.72 1,020,870
2014-10-13 AKRX Akorn Inc Option Ex 15,000 2.61 39,150
2014-05-15 INSY Insys Therapeutics, Inc. Buy 5,000 21.38 106,900
2012-12-12 AKRX Akorn Inc Sale 20,701 13.53 280,084
2012-12-12 AKRX Akorn Inc Option Ex 30,000 1.50 44,910
2010-12-13 AKRX Akorn Inc Buy 14,500 5.49 79,663
2010-05-25 AKRX Akorn Inc Buy 40,000 2.60 104,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meyer Steven J (Director of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.